Company profile

Elevara Medicines

Elevating efficacy for patients with rheumatoid arthritis and beyond.

Industry
Biotechnology Research
Employees
14
Founded
2025

Elevara Medicines company summary

Elevara Medicines is a company in the Biotechnology Research industry, founded in 2025. On LinkedIn the company has around 14 employees.

What technology does Elevara Medicines use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Elevara Medicines

Starting a new era in rheumatoid arthritis treatment. Elevara Medicines addresses a fundamental problem in rheumatoid arthritis (RA) where patients fail to achieve disease remission through immune targeted approaches. Proliferation and activation of fibroblast-like synoviocytes (FLS) is a central part of RA pathobiology and research over the last 20 years has shown these cells are direct contributors to the disease rather than innocent bystanders. By specifically targeting these cells, Elevara Medicines aims to break the efficacy ceiling patients experience with existing immunosuppressive drugs.

Compare companies similar to Elevara Medicines

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Elevara Medicines
elevara.com
Biotechnology Research142025-
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Elevara Medicines

What does Elevara Medicines do?

Starting a new era in rheumatoid arthritis treatment. Elevara Medicines addresses a fundamental problem in rheumatoid arthritis (RA) where patients fail to achieve disease remission through immune targeted approaches. Proliferation and activation of fibroblast-like synoviocytes (FLS) is a central part of RA pathobiology and research over the last 20 years has shown these cells are direct contributors to the disease rather than innocent bystanders. By specifically targeting these cells, Elevara Medicines aims to break the efficacy ceiling patients experience with existing immunosuppressive drugs.

How many employees does Elevara Medicines have?

Elevara Medicines has around 14 employees on LinkedIn.

When was Elevara Medicines founded?

Elevara Medicines was founded in 2025.

Build a lead list from companies like Elevara Medicines

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.